Clinical trial

Effect of Silibinin(A) as a Potential Anti-obesity Agent

NCT05069298

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-01-12

PhaseNA

Study timeline

Study start (actual)2023-01-12Date precision: day

Registry last updated2023-06-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Overweight and Obesityunresolved

Hypercholesterolemiaunresolved

Hypertriglyceridemiaunresolved

Interventions

Silibinin ADIETARY_SUPPLEMENT

Sponsors & collaborators

Universidad Católica San Antonio de Murcialead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05069298 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.